Cohen Fred E

CIK 000133935812 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001339358

Recent Transactions

50 trades

Award
CareDx, Inc.$CDNA
Common Stock
2026-06-12+9,795→ 165,060 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-06-09+9,200→ 216,653 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2026-06-09+13,300→ 13,300 total
Award
Kyverna Therapeutics, Inc.$KYTX
Stock Option (right to buy)
2026-05-27+20,582→ 20,582 total
Award
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2026-05-27+5,093→ 21,727 total
Purchase
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-01-05$9.35/sh+150,000→ 207,453 total
Award
CareDx, Inc.$CDNA
Common Stock
2025-06-13+12,103→ 155,265 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-06-11+8,000→ 57,453 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-06-11+11,450→ 11,450 total
Award
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2025-05-29+16,634→ 16,634 total
Award
Kyverna Therapeutics, Inc.$KYTX
Stock Option (right to buy)
2025-05-29+65,351→ 65,351 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2024-08-06+10,000→ 10,000 total
Award
CareDx, Inc.$CDNA
Common Stock
2024-06-14+10,570→ 143,162 total
Award
CareDx, Inc.$CDNA
Stock Option (right to buy)
2024-06-14+16,048→ 16,048 total
Award
CareDx, Inc.$CDNA
Stock Option (right to buy)
2024-06-14+16,048→ 16,048 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-06-12+7,737→ 49,453 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-06-12+11,515→ 11,515 total
Award
Progyny, Inc.$PGNY
Stock Option (Right to Buy)
2024-05-23+25,070→ 25,070 total
Award
Progyny, Inc.$PGNY
Common Stock
2024-05-23+6,176→ 22,693 total
Conversion
Kyverna Therapeutics, Inc.$KYTX
Series A-2 Redeemable Convertible Preferred Stock
2024-02-12−8,830,901→ 0 total
Conversion
Kyverna Therapeutics, Inc.$KYTX
Series A-1 Redeemable Convertible Preferred Stock
2024-02-12−4,401,771→ 0 total
Conversion
Kyverna Therapeutics, Inc.$KYTX
Series B Redeemable Convertible Preferred Stock
2024-02-12−7,356,162→ 0 total
Conversion
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2024-02-12+4,523,924→ 4,523,924 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2023-09-07+10,000→ 10,000 total
Award
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-07-26$9.54/sh+69,339→ 69,339 total
Award
CareDx, Inc.$CDNA
Common Stock
2023-06-16+29,136→ 29,136 total
Award
CareDx, Inc.$CDNA
Common Stock
2023-06-16+18,844→ 132,592 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-06-14+6,473→ 6,473 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-06-14+4,425→ 41,716 total
Award
Progyny, Inc.$PGNY
Stock Option (Right to Buy)
2023-05-24+18,350→ 18,350 total
Award
Progyny, Inc.$PGNY
Common Stock
2023-05-24+4,385→ 16,517 total
Award
CareDx, Inc.$CDNA
Common Stock
2023-01-06+1,062→ 113,748 total
Award
Progyny, Inc.$PGNY
Stock Option (Right to Buy)
2022-10-24+1,460→ 1,460 total
Award
Progyny, Inc.$PGNY
Stock Option (Right to Buy)
2022-10-24+15,660→ 15,660 total
Award
Progyny, Inc.$PGNY
Common Stock
2022-10-24+3,480→ 12,132 total
Award
CareDx, Inc.$CDNA
Common Stock
2022-10-04+803→ 112,686 total
Award
CareDx, Inc.$CDNA
Common Stock
2022-06-16+7,606→ 7,606 total
Award
CareDx, Inc.$CDNA
Common Stock
2022-06-16+4,863→ 111,883 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-06-14+5,197→ 37,291 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-06-14+7,688→ 7,688 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2022-06-08+10,000→ 10,000 total
Award
Progyny, Inc.$PGNY
Common Stock
2021-10-24+2,652→ 8,652 total
Award
Progyny, Inc.$PGNY
Stock Option (right to buy)
2021-10-24+15,831→ 15,831 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-06-23+2,094→ 2,094 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-06-23+3,382→ 3,382 total
Award
CareDx, Inc.$CDNA
Common Stock
2021-06-16+1,127→ 107,020 total
Award
CareDx, Inc.$CDNA
Stock Option (right to buy)
2021-06-16+1,812→ 1,812 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2021-06-07+10,000→ 10,000 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-01-20$13.78/sh+20,000→ 30,000 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-01-20−20,000→ 18,000 total

Cohen Fred E

Recent Transactions

Companies

Recent Filings

Address